DESCUBRIENDO AL COLANGIOCARCINOMA:
PRESENTACIONES ATÍPICAS
Palabras clave:
COLANGIOCARCINOMA, poster, seramResumen
Objetivos Docentes
Describir las presentaciones atípicas del colangiocarcinoma intrahepático en imagen, con especial atención a lesiones pequeñas incidentales.
Indicar los diagnósticos diferenciales a considerar ante lesiones indeterminadas hepáticas, incluyendo variantes atípicas en estadios precoces asintomáticos.
Evaluar la posibilidad de diseñar un cambio en el seguimiento propuesto por las guías de algunas de estas lesiones según el contexto y hallazgo en imagen.
Revisión del tema
El colangiocarcinoma intrahepático o periférico (CCI) se origina en la capa epitelial de los ductos biliares de segundo orden o superior. Representa un 15%-20% de todos los colangiocarcinomas y de acuerdo a su morfología y patrón de crecimiento se clasifica en formador de masa (60%), periductal infiltrativo e intraductal.
Descargas
Citas
- Kim YK, Lee JM, Kim CS (2004) Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004; 14:5–13
- Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005;237:938–944
- Kim SJ, Lee JM, Han JK, et al.Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 2007;189:1428–1434
- Jeon TY, Kim SH, Lee WJ, Lim HK. The value of gadobenate dimeglumine–enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 2010;35:337–345.
- Kim SA, Lee JM, Lee KB, et al.Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern–correlation with clinicopathologic findings. Radiology;2011,260:148–157
- Kang Y, Lee JM, Kim SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 2012; 264(3):751-60
- Park HJ, Kim YK, Park MJ, Lee WJ. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 2013;38(4):793–801.
- Najwa Al Ansari, Bong Soo Kim, Saowanee Srirattanapong et al. Mass-forming cholangiocarcinoma and adenocarcinoma of unknow primary:can they be distinguised on liver MRI?. Abdom Imaging 2014; 39:1228–1240
- Giuseppe Mamone, Gianluca Marrone, Settimo Caruso et al. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase. Abdom Imaging 2015;40:2313–2322
- Sharon Z. Adam, Sudharshan Parthasarathy, Frank H. Miller. Intrahepatic cholangiocarcinomas mimicking other lesions. Abdom Imaging 2015;40:2345–2354
- Yi-Jun Zhao,1 Wei-xia Chen,1 Dong-sheng Wu. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings. Abdom Radiol 2016. DOI: 10.1007/s00261-015-0629-z
- Jieun Koh,Yong Eun Chung, Ji Hae Nahm, et al.Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.Eur Radiol 2016; 26:407–416
